Literature DB >> 423004

Intracranial pressure and conductance to outflow of cerebrospinal fluid in normal-pressure hydrocephalus.

S E Børgesen, F Gjerris, S C Sørensen.   

Abstract

Forty patients with clinical evidence of normal-pressure hydrocephalus were studied by monitoring intraventricular pressure during a 24-hour period, and by a lumboventricular perfusion test for measurement of the conductance to outflow of cerebrospinal fluid (CSF). The purpose of the study was to investigate whether there is a relationship between intraventricular pressure and conductance to outflow of CSF, and whether it is possible to use the results from pressure monitoring in the selection of patients who may be expected to benefit from shunting therapy. The conductance to outflow was used as an evaluation factor in the selection of patients to be treated by a shunt. The conductance to CSF outflow differed by twelvefold between the lowest and highest values. The level of resting intraventricular pressure was within normal limits in all patients. Accordingly, there was no evidence of a relationship between conductance to outflow and intraventricular pressure. So-called B-waves were seen more frequently in patients with decreased conductance to outflow, but were also present in patients with high conductance to outflow. Therefore, the presence of B-waves does not imply a low conductance to outflow of CSF.

Entities:  

Mesh:

Year:  1979        PMID: 423004     DOI: 10.3171/jns.1979.50.4.0489

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called "normal pressure hydrocephalus" syndrome.

Authors:  J Sahuquillo; E Rubio; A Codina; A Molins; J M Guitart; M A Poca; A Chasampi
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  The relation of intracranial pressure B-waves to different sleep stages in patients with suspected normal pressure hydrocephalus.

Authors:  J K Krauss; D W Droste; M Bohus; J P Regel; R Scheremet; D Riemann; W Seeger
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  The role of cerebrospinal compensatory parameters in the estimation of functioning of implanted shunt system in patients with communicating hydrocephalus (preliminary report).

Authors:  W Maksymowicz; M Czosnyka; W Koszewski; A Szymanska; W Traczewski
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Xenon CT measurement of cerebral blood flow in hydrocephalus.

Authors:  P Maeder; N de Tribolet
Journal:  Childs Nerv Syst       Date:  1995-07       Impact factor: 1.475

5.  Isotope cisternography and conductance to outflow of CSF in normal pressure hydrocephalus.

Authors:  S E Børgesen; L Westergård; F Gjerris
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

6.  Conductance to outflow of CSF in normal pressure hydrocephalus.

Authors:  S E Børgesen
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

7.  Forecasting ICP elevation based on prescient changes of intracranial pressure waveform morphology.

Authors:  Xiao Hu; Peng Xu; Shadnaz Asgari; Paul Vespa; Marvin Bergsneider
Journal:  IEEE Trans Biomed Eng       Date:  2010-05       Impact factor: 4.538

8.  Quantitative analysis of continuous intracranial pressure recordings in symptomatic patients with extracranial shunts.

Authors:  P K Eide
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus.

Authors:  E Tedeschi; S G Hasselbalch; G Waldemar; M Juhler; P Høgh; S Holm; L Garde; L L Knudsen; L Klinken; F Gjerris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

10.  Colloid osmotic and hydrostatic pressures in chronic subdural haematomas.

Authors:  F Gjerris; S C Sørensen
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.